For example, MAPK pathway is involved in RANKL-induced breast cancer cell migration, and inhibition of MAPK pathway activation by specific inhibitors can effectively block RANKL-induced cell migration (43, 44). This evidence concerns the gene TNFSF11 and breast carcinoma.